A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation.

[1]  E. Elkord,et al.  Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells , 2005, Immunology.

[2]  M. Tomai,et al.  Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 , 2005, The Journal of Immunology.

[3]  S. Tyring,et al.  Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses. , 2004, Antiviral research.

[4]  B. Beutler,et al.  The interface between innate and adaptive immunity , 2004, Nature Immunology.

[5]  A. Órfão,et al.  A new simple whole blood flow cytometry-based method for simultaneous identification of activated cells and quantitative evaluation of cytokines released during activation , 2004, Laboratory Investigation.

[6]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[7]  S. Mahdavifar,et al.  Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. , 2004, Journal of immunological methods.

[8]  P. Haslett,et al.  Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. , 2004, Journal of immunological methods.

[9]  J. Lifson,et al.  Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells , 2004, Journal of Virology.

[10]  A. Mazzoni,et al.  Controlling the Toll road to dendritic cell polarization , 2004, Journal of leukocyte biology.

[11]  A. Sher,et al.  MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.

[12]  H. Young,et al.  Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells , 2004, Journal of leukocyte biology.

[13]  M. Kapsenberg.  Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.

[14]  A. Aderem,et al.  Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1 , 2003, The Journal of Immunology.

[15]  K. Okawa,et al.  Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. , 2002, Human immunology.

[16]  P. Fitzgerald-Bocarsly.  Natural Interferon-α Producing Cells: The Plasmacytoid Dendritic Cells , 2002 .

[17]  T. Kang,et al.  A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. , 2002, Cytokine.

[18]  R. Noelle,et al.  Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. , 2002, Cellular immunology.

[19]  M. Fenton,et al.  The role of Toll-like receptors in immunity against mycobacterial infection. , 2002, Microbes and infection.

[20]  Antonio Lanzavecchia,et al.  BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction , 2001, The Journal of experimental medicine.

[21]  N. Kadowaki,et al.  Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.

[22]  T. Kang,et al.  Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. , 2001, FEMS immunology and medical microbiology.

[23]  S. Ikehara,et al.  Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs1 , 2001, The Journal of Immunology.

[24]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[25]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[26]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[27]  J. Larrick,et al.  Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein , 1995, Infection and immunity.

[28]  C. Weeks,et al.  Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. , 1994, Journal of interferon research.

[29]  J. Lippincott-Schwartz,et al.  Brefeldin A: insights into the control of membrane traffic and organelle structure , 1992, The Journal of cell biology.

[30]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[31]  M. Colonna,et al.  Plasmacytoid dendritic cells , 2005, Immunologic research.

[32]  B. Pulendran.  Modulating Th1/Th2 responses with microbes, dendritic cells, and pathogen recognition receptors , 2004, Immunologic research.

[33]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[34]  V. Maino,et al.  Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. , 1998, Journal of immunological methods.

[35]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[36]  J. Blenis,et al.  Kinase-Mitogen-Activated Protein Kinase Signal-Regulated Modulation of Extracellular Distinct Th Responses via Differential Agonists Instruct Dendritic Cells to Induce Cutting Edge: Different Toll-Like Receptor , 2022 .